Apr. 24 at 6:24 PM
$UMAV
Lets GO!
🚀CNBX – Deep Value Biotech Flying Under the Radar 🚀
CNBX is one of those ultra-low market cap biotech plays that could move FAST when attention comes in.
💊 Cancer-Focused Pipeline
CNBX is developing multiple cannabinoid-based cancer therapies, including treatments targeting colorectal, breast, prostate, and melanoma cancers. Their lead candidates like Cannabics SR and RCC-33 are aimed at massive global markets. ()